|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06078 HYGEIA HEALTH
Nominal 
12.190 0.000 (0.000%) Ranking Overview
Ranking based on 6 research report(s)
Average Ranking 2.33
|
Strong Buy (1)
0
|
Buy (2)
4
|
Hold (3)
2
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2025 | EPS | 27.00 RMB (cts) | |
| Net Profit | 164.53 RMB (MIL) | DPS | 0.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2026 | 530.00 | 85.50 | 0 | -- | 617.00 | 467.00 |
| 2027 | 609.00 | 98.50 | 0 | -- | 714.00 | 541.00 |
| 2028 | 696.00 | 112.00 | 0 | -- | 696.00 | 696.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2026 | 503.00 | 79.90 | -- | CITIGROUP | Buy | 23.00 | 09/01/2026 | |
| 2026 | 467.00 | 75.00 | -- | UBS | Buy | 17.50 | 31/03/2026 | |
| 2026 | 617.00 | 100.00 | -- | MORGAN STANLEY | Overweight | 16.00 | 01/02/2026 | |
| 2026 | 538.00 | 87.00 | -- | CLSA | OutPerform | 15.90 | 03/02/2026 | |
| 2026 | 558.20 | 90.00 | -- | GOLDMAN SACHS | Neutral | 15.40 | 05/02/2026 | |
| 2026 | 522.00 | 84.00 | -- | SPDB INT'L SEC | Hold | 13.50 | 26/01/2026 | |
| 2027 | 541.00 | 86.00 | -- | CITIGROUP | -- | -- | 09/01/2026 | |
| 2027 | 605.00 | 98.00 | -- | UBS | -- | -- | 31/03/2026 | |
| 2027 | 714.00 | 115.00 | -- | MORGAN STANLEY | -- | -- | 01/02/2026 | |
| 2027 | 613.00 | 99.00 | -- | CLSA | -- | -- | 03/02/2026 | |
| 2027 | 629.00 | 101.00 | -- | GOLDMAN SACHS | -- | -- | 05/02/2026 | |
| 2027 | 595.00 | 96.00 | -- | SPDB INT'L SEC | -- | -- | 26/01/2026 | |
| 2028 | 696.00 | 112.00 | -- | UBS | -- | -- | 31/03/2026 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 02/04/2026 12:01 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 164,526 |
| %Change | -72.499% |
| EPS / (LPS) | RMB 0.270 |
| NBV Per Share (¥) | RMB -- |